The largest database of trusted experimental protocols

Kira8

Manufactured by MedChemExpress
Sourced in United States

KIRA8 is an advanced automated cell culture incubator designed for efficient and precise cell culture maintenance. It features precise temperature, humidity, and CO2 control to provide the optimal environment for cell growth and proliferation. The system's compact design and user-friendly interface make it a reliable and convenient tool for cell culture applications in research and clinical settings.

Automatically generated - may contain errors

4 protocols using kira8

1

Immortalized hSAECs for RSV and UPR Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immortalized primary hSAECs were obtained from American Type Culture Collection (ATCC, Gaithersburg, MD, USA) and grown in SAGM small airway epithelial cell growth medium (Lonza, Walkersville, MD, USA) in 5% CO2 (11 (link),16 (link)). Sucrose cushion purified RSV Long strain was prepared and titered using methylcellulose plaque assay (11 (link)). hSAECs were infected at a multiplicity of infection (MOI) of 1.0 for 24 h prior to harvest. For induction of the UPR, hSAECs were treated for indicated times with various standardly used doses of 0.5–0.5 μg/ml tunicamycin (TM) or 50 nM thapsigargin (Tg). The selective IRE1α RNAse inhibitor KIRA8 (MedChemExpress, South Brunswick Township, NJ, USA) was added directly to the culture medium at a concentration of 10 μM where indicated (17 (link)).
+ Open protocol
+ Expand
2

Chemical and Growth Factor Modulation of Midbrain Dopaminergic Neuron Survival

Check if the same lab product or an alternative is used in the 5 most similar protocols
For chemical treatment, the primary midbrain neurons at 14 DIV were exposed to vehicle (dimethyl sulfoxide, DMSO), 10 nM thapsigargin (an ER stress inducer, Sigma-Aldrich, #T9033), 100 nM GSK2606414 (a PERK inhibitor, MedChemExpress, #HY-18072)66 (link), or 100 nM KIRA8 (an IRE1α inhibitor, MedChemExpress, #HY-114368)67 (link) for 48 or 96 h. For growth factor deprivation, the primary midbrain neurons at 14 DIV were deprived of growth factor by lowering the content of N2/B27 supplement in the culture medium from 1× to 0.1× for 48 h. After chemical treatment or growth factor deprivation, neurons were fixed with 4% PFA/PBS and immunostained with TH antibody and secondary antibody. The number of TH-positive neurons on each coverslip was counted under the confocal microscope with a ×40 objective. Counters were blinded to the genotypes and treatments of the samples. The survival rate of DAergic neurons was calculated by dividing the number of TH-positive neurons on each coverslip by the number of TH-positive neurons on the control coverslip (neurons from Dctn1LoxP/LoxP P0 pups treated with vehicle or cultured in normal medium)62 (link).
+ Open protocol
+ Expand
3

Immortalized hSAECs: RSV Infection Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
hSAECs are immortalized primary human small airway epithelial cells [65 (link)] from ATCC (PCS-301-010, at passage 2). hSAECs were grown in SAGM small airway epithelial cell growth medium (Lonza, Walkersville, MD, USA) and used at passage 4. hSAECs undergo growth factor-induced cell-state transition [66 (link)] and maintain RSV-induced genomic and proteomic signatures representative of primary cells [27 (link)]. The human RSV long strain was grown in Hep-2 cells, prepared by sucrose cushion purification, tittered by methylcellulose plaque assay [26 (link),67 (link)] and quick-frozen until use. The selective IRE1α RNAse inhibitor KIRA8 (MedChemExpress, South Brunswick Township, NJ, USA) [68 (link)] was applied to the cells 2 h prior to RSV infection.
+ Open protocol
+ Expand
4

Sendai Virus Infection Alleviation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animal experiments were performed according to the NIH Guide for Care and Use of Experimental Animals and approved by the University of Wisconsin at Madison Institutional Animal Care and Use Committee (Approval No. 1312058 A). Wild-type 7-wk-old C57BL/J6 black mice (both sexes) were administered Sendai Virus (SeV, 104 PFU, Cantell Strain, ATCC) or vehicle (PBS) via the intranasal route. Randomly selected mice were then treated every day with an IRE1α inhibitor (KIRA8, 50 mg/kg/day; MedChemExpress, NJ) for 3 days via the intraperitoneal route starting 24 h after SeV infection. KIRA8 solution at 6 mg/mL was prepared using 10% DMSO-90% corn oil formula and maintained at 37°C for smooth injection. In a separate study, wild-type 7-wk-old C57BL/J6 black mice were administered Sendai Virus (SeV, 104 PFU) or vehicle (PBS) and euthanized at day 7. In both studies, lung tissues were collected for preparing FFPE tissue slides for immunofluorescence staining and Q-RT-PCR analysis. Bronchoalveolar lavage fluid (BALF) was also collected for proteomic analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!